L3Harris owns durable defense electronics and a near-monopoly in solid rocket motors via Aerojet, yet the stock trades at $313 against a base IV of $154 — you are paying 40x earnings for a 3.6% ROIC business levered 3.2x. Wait for the price.

Plain English

L3Harris makes the radios soldiers carry, the jamming pods on fighter jets, the cameras on spy satellites, and the rocket motors in missiles. Almost all customers are the US Government and allied militaries. It is a very stable business — the products take decades to qualify, so once you are in a program, no one kicks you out. But the government is the only buyer and squeezes the price hard, so the company earns only modest returns on the money invested. Today the stock costs about twice what the business is worth based on the cash it produces.

Thesis

L3Harris Technologies (LHX) is the No. 6 US defense prime — tactical radios, electronic warfare, ISR sensors, night-vision, satellite payloads, and (since 2023) Aerojet Rocketdyne solid rocket motors. The thesis for owning it is straightforward: defense budgets are structurally rising on a multi-decade rearmament cycle (Ukraine, Indo-Pacific, missile-defense rebuild), Aerojet is a duopoly supplier of solid rocket motors with a $20B+ backlog and pricing power, and the legacy Harris tactical radio franchise is the de-facto NATO standard with high switching costs.

The problem is the price. The scorecard is unambiguous: ROIC 10y avg of 3.65% — barely cost of capital; ROIIC 5y of 48.4% looks great but is flattered by the Aerojet acquisition timing and post-COVID cost-out; FCF/NI conversion of 1.53x is genuinely strong (no working-capital sink). Net debt/EBITDA of 3.17x is elevated post-Aerojet. Share count is up 6.6% over 10 years (issued for L3 merger and Aerojet) — dilutive, not accretive.

Valuation does the rest of the talking: P/E TTM 40.5x vs 10y average 37.7x — paying a premium to an already premium-priced stock. EV/FCF of 40.6x. Reverse-DCF implied growth: 20.2% — that is hyperscaler growth, not defense-prime growth. IV base $153.51, IV high $194.36, current $313.37 — a price/IV ratio of 2.04x. Even bull-case IV is exceeded by 61%. Composite score 57/100 with valuation a punishing 7/100.

The math: at IV-base $154 you would buy with conviction; at IV-high $194 it is full but defensible; at $313 you are buying a defense business at a software multiple. Recommendation: Avoid at this price, watch for $200 entry.

Moat

L3Harris's competitive position is real but narrower than the price implies. Working through the five moat sources:

Intangibles (program incumbency, security clearances, certifications) — STRONGEST. Defense procurement runs on multi-decade programs of record. Once a radio family (Falcon III/IV), an EW system (AN/ALQ-211), or a rocket motor (Standard Missile, GMLRS, Trident) is qualified, the cost and schedule risk of switching suppliers is enormous. LHX's Aerojet unit is one of only two qualified solid rocket motor producers in the US (Northrop Grumman the other), giving it duopoly economics on missile motors that the DoD is now scrambling to scale. Tactical radios (Falcon series) are the NATO-interoperable standard with installed base in the millions of units. Top Secret/SCI cleared workforces and SCIF facilities are themselves an entry barrier.

Switching costs — STRONG, though program-specific. Once integrated into a platform (F-35 EW, Tomahawk seeker, Trident D5 motor), LHX content is nearly impossible to displace mid-program. The customer (DoD) is locked in by qualification testing, certification, and lifecycle support. This shows in the high book-to-bill (~1.1-1.2x) and $34B+ backlog providing 1.5x revenue visibility.

Cost advantages — WEAK. LHX is not a low-cost producer; cost-plus and FFP contracting compresses margins around 12-15% operating, and the supplier base (specialty alloys, semiconductors, energetics) gives LHX no purchasing leverage versus Lockheed/Raytheon. Buffett's discussion of Precision Castparts [1] is instructive — defense supply chains were brutal in 2020-2023 and only just normalizing. Note also: LHX's 10y ROIC of 3.65% is the smoking gun — true cost-advantage moats produce 15%+ ROIC, not sub-cost-of-capital returns.

Pricing power — MODERATE. On sole-source programs (Aerojet motors, certain ISR payloads) LHX has clear pricing power evidenced by post-merger price increases now flowing through. On competed programs (radios, satellites) it is a price-taker against Northrop, Raytheon, Collins, and increasingly cheap commercial-off-the-shelf alternatives. The DoD's renewed focus on "commercial alternatives" and Anduril/SpaceX-style new entrants is a real margin threat over 10 years.

Network effects — NONE meaningful. Some interoperability advantages in tactical radio mesh networks, but not classic network effects.

Competitor stress test ($10B and 5 years) — Could a competitor with $10B and 5 years displace LHX? On Aerojet motors: NO — qualifying a new solid rocket motor takes 7-10 years and DoD would not certify a single-source upstart. On Falcon radios: PARTIALLY — Anduril, Silvus, and Persistent Systems are taking share at the squad/drone level; the high-end mil-spec moat holds. On EW/ISR: defense is genuinely hard to disrupt at scale — multi-decade programs protect incumbents.

Erosion risks — Three real ones: (1) DoD's drift toward commercial-tech and Anduril-style fixed-price competitors; (2) the post-Aerojet integration risk — Aerojet had quality and execution problems for years that LHX inherited; (3) consolidation has gone about as far as antitrust will allow, so LHX cannot M&A its way to higher returns without paying premium prices (it paid $4.7B for Aerojet, ~17x EBITDA).

The ROIC truth-test matters enormously here. Buffett [3] looks for businesses with "durable advantages and long-term economic prospects" — that is defense at the franchise level, but LHX's 3.65% ROIC says the franchise economics flow more to the customer (DoD) than to shareholders. Compare to Precision Castparts pre-2025 [4] — a great franchise that earned poor returns for years because its end-market was tough.

Moat verdict: NARROW. Real on programs of record and Aerojet duopoly; narrow because LHX has not converted the moat into excess returns on capital, and the customer concentration (~75% US Government) caps pricing.

Management

Christopher Kubasik (CEO since 2021) inherited the L3-Harris merger integration and immediately doubled down with the $4.7B Aerojet Rocketdyne acquisition (closed July 2023). The strategy — rebrand as the "Trusted Disruptor," exit non-core, rationalize the segment count from four to three, harvest LHX-Next cost-out (~$1B target) — is coherent and well-communicated. Communication quality is above-average; investor day targets and segment disclosures are detailed. But the capital allocation track record needs scrutiny.

Reinvest — Organic R&D runs ~3-4% of sales, modest by tech standards but reasonable given defense customer-funded IRAD/CRAD model. Capex is light at ~2-3% of sales. The high FCF/NI conversion (1.53x per scorecard) confirms the business does not eat capital. Grade here: B.

Acquire — This is where the story gets tense. The Harris-L3 "merger of equals" in 2019 was rationalized as cost synergies; results have been mixed (the 6.6% share count growth over 10 years tells you the equity issued was not fully recovered through buybacks). The Aerojet deal at ~17x EBITDA was strategically sound (only solid-rocket-motor merchant supplier left) but financially expensive — net debt/EBITDA jumped to 3.17x and the implied ROIC on Aerojet purchase price is in the 5-7% range absent meaningful synergies. Aerojet had documented execution and quality issues that LHX is still working through. The 48.4% ROIIC is statistically attractive but reflects denominator effects (low base, post-COVID recovery) more than acquisition skill. Grade here: C+.

Debt — Levering up to 3.2x net debt/EBITDA for an acquisition in a cyclical (yes, defense IS cyclical over decades) industry at the top of a budget cycle is aggressive. To Kubasik's credit, the company is now committed to deleveraging to ~3.0x and has paused buybacks to do so — but the debt was taken on near peak rates. Interest coverage data is missing from the scorecard, which is itself a yellow flag in a 3x-levered name.

Buybacks — Here is the concerning part. LHX bought back stock heavily in 2020-2022 at average prices in the $200-260 range; given current IV-base of $153.51, those buybacks were executed at 1.3-1.7x IV — a value-destructive use of capital. They have rightly paused, but the historical pattern is to buy back high and pause low. Compare to Buffett's discipline [3]: "Act quickly and concentrate our capital in a few high conviction ideas... Maintain discipline and let compounding unfold." LHX has not demonstrated this discipline at the buyback line.

Dividends — Steady ~2% yield, growing low-single-digits. This is fine; defense investors expect it. Not a value-creation lever but not destructive.

Communication — Kubasik is clear, specific with numbers, willing to walk through misses. Segment reporting is good. The post-Aerojet realignment was telegraphed in advance. Tone is salesman-y but substantive. Probably an A- on disclosure, B on candor about misses.

Insider alignment — Insider ownership is low (<0.5%), typical for a defense prime. Compensation is heavily TSR-linked which can drive short-termism. No founder-operator dynamic.

The core problem with capital allocation is the gap between ROIIC (48%) and ROIC (3.65%). This wide gap usually means either (a) recent investments are dramatically better than the legacy base — possible if Aerojet and LHX-Next are genuine — or (b) ROIIC is inflated by working-capital releases, divestiture cash-ins, or denominator effects. With the FCF conversion of 1.53x, much of the ROIIC gain is real cash, but the durability is unproven at one cycle.

Capital allocator: B-.

Industry

Porter's Five Forces on US/allied defense electronics:

Buyer power — VERY HIGH. The US Government (DoD, NASA, intelligence community) is ~75% of LHX revenue and a structural monopsony. Foreign Military Sales add allied governments — still few buyers, all sophisticated. Buyers control the procurement rules, mandate cost-plus accounting on major programs, can impose progress payments, dictate audit rights (DCAA), and can — and do — re-compete programs. The Trump-2 administration's DOGE effort and "commercial alternatives" push (favoring Anduril, SpaceX, Palantir) is actively eroding prime-contractor pricing power on new starts. This is the single biggest force in the industry.

Supplier power — MODERATE-HIGH and rising. Specialty alloys (PCC, titanium), advanced semiconductors (Trusted Foundry), energetics (AP, HMX), rare earths, and skilled cleared labor are all constrained. The 2021-2023 supply chain crunch hit defense hard and lingers. Aerojet itself was a tight supplier — which is exactly why LHX bought it. LHX is partially vertically integrated, mitigating but not eliminating supplier power.

Rivalry — MODERATE among primes, RISING from new entrants. Among the traditional primes (LMT, RTX, NOC, GD, BA, LHX), rivalry is structured by program competition rather than price wars within program. Bidding is sophisticated, often two-team teaming arrangements, and program awards are sticky once won. New entrants (Anduril, Shield AI, SpaceX, Saronic, Palantir) are a different threat — well-capitalized, software-native, willing to take fixed-price risk, and explicitly favored by current DoD acquisition reform. They have already won OTAs and small programs; the next decade will tell whether they can scale to true prime status. If they do, the high-margin program-of-record incumbency moat erodes.

Substitutes — MODERATE and rising. Commercial satellite imagery, commercial space launch, commercial 5G/Starlink communications, and software-defined warfare (autonomous systems, AI/ML) all pressure traditional bespoke mil-spec hardware. The threat is not zero-substitution — fighter jets and missiles are not substitutable — but at the platform-electronics layer, commercial-derivative solutions are increasingly credible.

Barriers to entry — VERY HIGH. Security clearances, SCIF infrastructure, ITAR/EAR compliance, qualification testing (e.g., 7-10 years for solid rocket motors), program-of-record relationships, ITAR-cleared workforce, capital intensity at certain scales. This is the dominant moat factor protecting incumbents — and explains why despite weak ROIC, defense primes are still standalone businesses rather than commodity suppliers.

Value pool location and trajectory. The value pool sits with: (a) prime systems integrators on long-cycle programs (LMT F-35, RTX missiles, NOC bombers); (b) sole-source critical components (Aerojet motors, Trusted Foundry chips); (c) software/data layer (Palantir, increasingly RTX/LMT software); and (d) rapidly: drone-and-software new entrants (Anduril). LHX is positioned (b) and (a) but not (c) or (d). The value pool is GROWING in absolute terms — global defense spending is rising — but SHIFTING toward (c) and (d) at the margin. LHX must invest to stay relevant; this caps free cash and ROIC for years.

The industry generates returns above commodity manufacturing but well below software. ROIC for the prime cohort sits 8-12% on average; LHX's 3.65% is below cohort, reflecting elevated goodwill from L3 and Aerojet deals. The industry is structurally OK but not Excellent because the customer is one buyer with extraordinary power and is currently changing the rules.

Industry Verdict: Average. Better than commodity manufacturing, well below software/network-effect industries. Stable but not improving.

Inversion

The single event that kills this. A 2026-2028 DoD budget plateau or fiscal cliff. The current US deficit (~6% of GDP) is unsustainable, and entitlement+interest growth are crowding out discretionary. A Republican Congress + bond-market revolt + DOGE-style review = real defense flat-lining or modest cuts. Combine with a Ukraine ceasefire that releases $30-50B of pent-up munitions demand, and LHX revenue growth flips from +5% to flat overnight while the multiple compresses 30-40%. At a normalized 18-22x earnings on $9-10 EPS, the stock is $180-220 — a 30-40% drawdown from $313.

Why the moat is narrower than bulls think. The 3.65% 10y ROIC is the entire bear case in one number. If the moat were as wide as bulls believe — sticky programs of record, high switching costs, sole-source content — ROIC would be 12-18%, like Lockheed in its best decade. Instead LHX earns barely cost-of-capital. Two reasons: (1) goodwill from L3 and Aerojet deals inflates the denominator and reflects overpayment; (2) the customer (DoD) extracts the franchise rents through cost-plus, EAC reviews, audit rights, and constant re-competition. The Aerojet duopoly is real but DoD has been actively shopping for a third merchant supplier (Anduril, X-Bow, Ursa Major) and has funded multiple alternatives. Within 5 years, expect a credible third source on small/medium SRMs. Tactical radios face Anduril/Silvus/Persistent at the low end and software-defined-radio commoditization. The moat is real but eroding from both ends.

Why management is worse than it appears. Three signals. (1) The buyback record is bad — repurchases concentrated in 2020-2022 at $200-260 per share, which is 1.3-1.7x current IV-base of $153.51. Real value-destructive capital allocation. (2) The Aerojet deal economics are mediocre at $4.7B / ~17x EBITDA, against an asset that had documented quality and execution problems. The thesis is duopoly+synergies; the reality so far is integration drag and write-offs. Buffett [3] would say this is exactly the deal not to do — paying full price for a problem child in a cycle peak. (3) The 6.6% share count growth over 10 years means net dilution despite billions in buybacks. Net-net the equity has been used, not compounded. Communication is good but the actions don't match Buffett-grade discipline.

What bulls are extrapolating that won't hold. Bulls extrapolate (a) sustained ~5-7% revenue growth from rearmament, (b) 250-300 bps of margin expansion from LHX-Next cost-out, (c) Aerojet returning to 16-18% margins on a $4-5B revenue base, and (d) multiple expansion as defense outperforms. Each is independently questionable; together they require all four to work, which is the lollapalooza of bull cases. The reverse-DCF says you need 20.2% growth at current price — far above the 5-7% bulls actually model. The market is implicitly pricing perfect execution, persistent budget tailwinds, and multiple sustainability — three independent conditions, each ~70% probable, for a joint probability of ~34%. You are paying a 100% probability price for a 34% scenario.

Valuation trap (multiple compression / regime change). P/E 40.5 vs 10y avg 37.7 — already above its own elevated range. EV/FCF 40.6x. P/IV 2.04x. Defense primes historically trade at 14-20x earnings; LHX traded at 14-18x as recently as 2018-2020. A reversion to even the 25-30x range (giving full credit to the franchise but returning to historical premium) implies a $200-240 stock — 20-35% downside. A reversion to defense-prime mean of ~18x on $9 EPS = $162 — 48% downside. Add 3.2x net debt/EBITDA, missing interest coverage data on the scorecard, and any modest EBITDA decline causes covenant pressure and a forced deleveraging — a classic value trap. Compare to Precision Castparts pre-Berkshire [4]: a great franchise that earned poor returns for years through a tough cycle. The 2026 LHX investor is buying at peak multiple, peak budget, peak optimism — exactly the opposite of when Buffett buys.

If I am right, the stock could be worth $160-200 within 2-3 years — a 36-49% drawdown from $313, with a chart that probably looks like 2022 LMT (sideways while fundamentals catch up to multiple) rather than a violent crash.

Lollapalooza Bias Check

Several biases are pulling at the analyst right now and I should name them.

Authority/social proof. Defense primes are the consensus-comfortable holding for institutional money — Buffett owns LMT and BA-related, Druckenmiller has rotated through, every macro fund is long defense on rearmament. The pull is to ratify the consensus: "if everyone smart owns defense, it must be cheap." The scorecard says it isn't. I am consciously discounting the consensus bull-narrative weight. Buffett [3] reminds me: high conviction comes from the work, not the crowd.

Recency bias. The Ukraine war, Israel-Iran exchanges, and Indo-Pacific tensions are vivid and recent. The brain wants to extrapolate "forever rearmament." History says defense is cyclical on multi-year time-frames; the last drawdown (2013-2016 sequestration) is far enough back that emotional memory has faded. I am consciously pulling forward the historical base rate (mean reversion in defense multiples and budgets every 7-12 years).

Anchoring on the L3-Harris merger thesis. The 2019 merger and 2023 Aerojet deal anchored a "Trusted Disruptor scaling franchise" narrative. The price has tripled from 2020 lows. The anchor wants me to validate the run. The scorecard's 3.65% 10y ROIC and 2.04x P/IV ratio say the price has run ahead of the franchise economics.

Confirmation bias toward the bear case. Having identified the 7/100 valuation score early, I am at risk of cherry-picking bear evidence and dismissing bull evidence. To check: I deliberately wrote the moat section before the inversion to give the bull case its strongest fair hearing. The honest answer is the franchise is real and durable — the disagreement is purely on price.

Commitment/consistency. Once you write "Avoid" you defend it. To inoculate: my actual recommendation is "Avoid at $313, Buy under $200" — not a permanent dismissal of the business. If the price came to me, the franchise quality would justify ownership.

Deprival super-reaction. I do not currently own LHX, so deprival is muted on the long side. If LHX ran to $400 while I waited, I would feel the deprival. Naming it now reduces its decision-time pull.

Incentive bias (others, not mine). Sell-side analysts and defense-focused funds are structurally long-biased and incentivized to maintain Buy ratings. The price-target distribution is therefore right-skewed. I should mentally discount the modal sell-side IV.

Net: the strongest active bias is recency (rearmament narrative) and authority (consensus is long). Both push toward owning at any price; both are systematically corrected by the scorecard discipline.

10-Year Outlook

Same fundamental business model in 2036? Yes, with high confidence. LHX in 2036 will still be selling tactical radios, EW systems, ISR sensors, satellite payloads, and rocket motors to the US Government and allies. The business shape is highly stable.

Customer base larger? Modestly. The US DoD will still be ~70% of revenue. Allied FMS will likely grow share (NATO rearmament, AUKUS, Indo-Pacific allies) — perhaps 25-35% of revenue versus ~20% today. Commercial space and intelligence community modestly larger. No transformational customer expansion.

Profit per customer higher? Probably modestly higher in nominal terms, roughly flat in real terms. LHX-Next cost-out gives 200-300 bps margin headroom; offset by DoD pricing pressure on follow-on competitions, commercial-substitute pricing, and the secular trend toward fixed-price contracting. Net: 13-15% operating margin range, vs ~14% today.

Moat wider? No — likely modestly narrower. New entrants (Anduril, Shield AI, SpaceX, X-Bow, Saronic) are eroding the prime-incumbency moat at the edges. Aerojet's duopoly will probably become a tri-opoly within 7-10 years as DoD funds alternatives. Counterbalancing: program-of-record inertia is real and slow.

Single biggest threat? A sustained DoD budget plateau combined with the success of new-entrant primes taking 10-15 points of share at the systems level. Secondary threat: fiscal/debt-driven cuts forced by deficit dynamics in late 2020s.

Confidence in the 10-year picture. The business existing and roughly resembling itself — high confidence. The economic returns being adequate to justify $313 — low confidence. The reverse-DCF requires 20%+ growth which the structure cannot deliver. At $313 you are betting that this stable but cycle-bound franchise will achieve hyperscaler economics; the structural analysis says no.

The 10-year-forward shape is clear enough that this is NOT a Too-Hard situation — defense electronics in 2036 is knowable. The price-to-IV is the entire problem.

CONFIDENCE: medium

Position Guidance

• Recommendation: Avoid (at $313)
• Conviction: Medium-High
• Target buy price: $180 (within 15% of IV-base $153.51, ~25% margin of safety)
• Target trim price: $210 (above IV-high $194.36; defensible only on bull-case scenarios)
• Position sizing: 0% at current price. If price comes to $180-200 range, justify a 2-4% position. Reserve larger sizing (5-7%) for IV-base or below ($150-170), which would require a defense-budget-driven correction or a bad-news event in Aerojet integration.
• Watch triggers: (1) Defense budget topline announcement for FY27; (2) Aerojet integration milestones / write-down risk; (3) Tactical radio competitive losses to Anduril/Silvus; (4) Net debt/EBITDA progression toward 2.5x or below.